Milestone Pharmaceuticals

(NASDAQ) MIST

Current Price$1.86

Market Cap$211.80M

Since IPO (2019)-88%

5 Year-69%

1 Year+36%

1 Month+51%

Milestone Pharmaceuticals Financials at a Glance

Market Cap

$211.80M

Revenue (TTM)

$1.55M

Net Income (TTM)

$63.06M

EPS (TTM)

$-0.80

P/E Ratio

-2.26

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Price

$1.86

Volume

27,844

Open

$1.80

Price

$1.86

Volume

27,844

Open

$1.80

Previous Close

$1.86

Daily Range

$1.77 - $1.89

52-Week Range

$1.00 - $3.06

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Price

$1.86

Volume

27,844

Open

$1.80

Previous Close

$1.86

Daily Range

$1.77 - $1.89

52-Week Range

$1.00 - $3.06

MIST News

Should You Buy This Biotech Stock Before It Starts Soaring?

David HaenMar 10, 2020

MIST: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Milestone Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Joseph G. Oliveto, MBA

Website

www.milestonepharma.com

Headquarters

Montreal, QC H4M 2X6, CA

MIST Financials

Key Financial Metrics (TTM)

Gross Margin

96%

Operating Margin

-40%

Net Income Margin

-41%

Return on Equity

-230%

Return on Capital

-63%

Return on Assets

-56%

Earnings Yield

-44.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$211.80M

Shares Outstanding

117.67M

Volume

27.84K

Avg. Volume

2.10M

Financials (TTM)

Gross Profit

$1.43M

Operating Income

$62.48M

EBITDA

$62.14M

Operating Cash Flow

$49.04M

Capital Expenditure

$302.00K

Free Cash Flow

$49.34M

Cash & ST Invst.

$105.96M

Total Debt

$58.38M

Milestone Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$1.55M

N/A

Gross Profit

$1.51M

+366.7%

Gross Margin

97.80%

N/A

Market Cap

$211.80M

N/A

Market Cap/Employee

$6.42M

N/A

Employees

N/A

Net Income

$17.41M

-40.8%

EBITDA

$17.32M

-58.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$47.58M

+219.4%

Accounts Receivable

$3.51M

+46.7%

Inventory

$648.00K

N/A

Long Term Debt

$57.73M

+6.5%

Short Term Debt

$647.00K

+13.3%

Return on Assets

-55.53%

N/A

Return on Invested Capital

-62.57%

N/A

Free Cash Flow

$12.79M

-86.2%

Operating Cash Flow

$12.78M

-86.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ELTXElicio Therapeutics, Inc.

ELTXElicio Therapeutics, Inc.$10.75+1.22%

MOLNMolecular Partners AG

MOLNMolecular Partners AG$4.31+1.89%

IPHAInnate Pharma S.A.

IPHAInnate Pharma S.A.$1.42-1.39%

CRBPCorbus Pharmaceuticals Holdings, Inc.

CRBPCorbus Pharmaceuticals Holdings, Inc.$10.30+4.25%

PEPGPepGen Inc.

PEPGPepGen Inc.$1.75+6.71%

CRDFCardiff Oncology, Inc.

CRDFCardiff Oncology, Inc.$1.71-1.16%

RANIRani Therapeutics Holdings, Inc.

RANIRani Therapeutics Holdings, Inc.$0.94+5.87%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.05+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.68+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.33+0.03%

NIONio

NIONio$5.92-0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.21-0.03%

MARAMara Holdings

MARAMara Holdings$11.44-0.05%

FFord Motor Company

FFord Motor Company$11.88-0.02%

Questions About MIST

What is the current price of Milestone Pharmaceuticals?

Milestone Pharmaceuticals is trading at $1.87 per share.

What is the 52-week range for Milestone Pharmaceuticals?

Over the past 52 weeks, Milestone Pharmaceuticals has traded between $1.00 and $3.06.

How much debt does Milestone Pharmaceuticals have?

As of the most recent reporting period, Milestone Pharmaceuticals reported total debt of $58.38M.

How much cash does Milestone Pharmaceuticals have on hand?

Milestone Pharmaceuticals reported $73.05M in cash and cash equivalents in its most recent financial results.

What is Milestone Pharmaceuticals’s dividend yield?

Milestone Pharmaceuticals does not currently have a dividend yield.

Milestone Pharmaceuticals

Milestone Pharmaceuticals Financials at a Glance

MIST News

Should You Buy This Biotech Stock Before It Starts Soaring?

MIST: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Milestone Pharmaceuticals

MIST Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Milestone Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MIST

What is the current price of Milestone Pharmaceuticals?

What is the 52-week range for Milestone Pharmaceuticals?

How much debt does Milestone Pharmaceuticals have?

How much cash does Milestone Pharmaceuticals have on hand?

What is Milestone Pharmaceuticals’s dividend yield?

Premium Investing Services